0
Signin
countryflagUK

8082-737-676

0R15 9870.0 1.7211% 0R1E 8480.999 -0.749% 0M69 None None% 0R2V 213.5 0.0% 0QYR 1302.5 -1.994% 0QYP 443.0 8.4455% 0RUK 2822.0 -3.4223% 0RYA 1400.0 -5.5968% 0RIH 176.8 0.369% 0RIH 176.8695 0.4085% 0R1O 183.75 9900.0% 0R1O None None% 0QFP None None% 0M2Z 289.7 -0.6431% 0VSO 27.31 -23.2973% 0R1I None None% 0QZI 501.0 -0.7921% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 1699.493 0.3881%

Eden Research plc

Basic Materials GB EDEN

4.2GBP
0.05(1.20%)

Last update at 2024-06-14T16:59:00Z

Day Range

3.824.40
LowHigh

52 Week Range

3.0012.16
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -2.56759M -3.39568M -2.54813M -1.47937M -0.53307M
Minority interest 0.00662M -0.01143M 0.02M 0.01M 0.01M
Net income -2.24388M -2.77754M -2.26302M -1.13234M -0.33495M
Selling general administrative 2.75M 2.69M 2.20M 1.54M 1.52M
Selling and marketing expenses - - - - -
Gross profit 0.83M 0.56M 0.63M 0.88M 1.54M
Reconciled depreciation 0.69M 0.59M 0.62M 0.52M 0.43M
Ebit -2.56703M -3.20828M -2.23569M -1.35762M -0.49704M
Ebitda -1.85811M -2.77364M -1.60176M -0.95217M -0.06717M
Depreciation and amortization 0.71M 0.43M 0.63M 0.41M 0.43M
Non operating income net other - - - - -
Operating income -2.56703M -3.20828M -2.23569M -1.35762M -0.49704M
Other operating expenses 4.39M 4.44M 3.60M 3.41M 3.27M
Interest expense 0.02M 0.03M 0.02M 0.00840M 0.00168M
Tax provision -0.32372M -0.61814M -0.28511M -0.34704M -0.19812M
Interest income 0.00019M 0.00010M 0.00573M 0.00081M 0.00168M
Net interest income -0.02185M -0.03198M -0.01827M -0.00759M 0.00113M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.32372M -0.61814M -0.28511M -0.34704M -0.19812M
Total revenue 1.83M 1.23M 1.37M 2.05M 2.77M
Total operating expenses 3.40M 3.77M 2.87M 2.24M 2.03M
Cost of revenue 1.00M 0.67M 0.74M 1.16M 1.24M
Total other income expense net -0.00056M -0.18740M -0.31244M -0.12176M -0.03603M
Discontinued operations - - - - -
Net income from continuing ops -2.24388M -2.77754M -2.26302M -1.13234M -0.33495M
Net income applicable to common shares - -2.78897M -2.27035M -1.14470M -0.33495M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 12.91M 15.03M 16.92M 8.86M 9.22M
Intangible assets 8.45M 7.92M 6.73M 5.58M 5.02M
Earning assets - - - - -
Other current assets - 1.79M 1.68M 1.90M 0.92M
Total liab 2.17M 2.20M 2.00M 1.52M 0.94M
Total stockholder equity 10.72M 12.80M 14.91M 7.34M 8.28M
Deferred long term liab - 5.44M 4.13M 2.88M 2.26M
Other current liab 0.66M 0.56M 0.66M 0.48M 0.38M
Common stock 3.81M 3.80M 3.80M 2.07M 2.07M
Capital stock 3.81M 3.80M 3.80M 2.07M 2.07M
Retained earnings -43.30944M -41.46075M -38.84226M -36.57191M -35.94762M
Other liab - 0.09M 0.13M 0.10M 0.07M
Good will - - - - -
Other assets - 5.44M 4.13M 2.88M 2.26M
Cash 1.99M 3.83M 7.29M 0.50M 2.48M
Cash and equivalents - - - - -
Total current liabilities 1.95M 1.81M 1.54M 1.37M 0.88M
Current deferred revenue - - - - -
Net debt -1.63915M -3.43102M -6.87125M -0.43249M -2.47874M
Short term debt 0.14M 0.10M 0.08M 0.02M -
Short long term debt - - - - -
Short long term debt total 0.36M 0.40M 0.42M 0.07M -
Other stockholder equity 50.22M 50.46M 49.95M 41.84M 42.15M
Property plant equipment - 0.61M 0.58M 0.06M -
Total current assets 3.60M 6.14M 9.19M 2.47M 3.41M
Long term investments - - - - 0.79M
Net tangible assets - 10.32M 12.31M 4.63M 5.52M
Short term investments - - - - -
Net receivables 0.32M 1.77M 1.49M 1.75M 0.84M
Long term debt - - - - -
Inventory 0.63M 0.52M 0.22M 0.07M 0.01M
Accounts payable 1.15M 1.15M 0.79M 0.87M 0.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -0.07147M -0.05278M -
Additional paid in capital - - - - -
Common stock total equity - - 3.80M 2.07M 2.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.33M 0.36M 0.42M 0.75M -5.01651M
Deferred long term asset charges - - - - -
Non current assets total 9.31M 8.89M 7.73M 6.39M 5.81M
Capital lease obligations 0.36M 0.40M 0.42M 0.07M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.05400M -1.72610M -1.89632M -0.91304M -0.51093M
Change to liabilities - 0.16M 0.11M 0.36M -1.15709M
Total cashflows from investing activities - -1.72610M -1.89632M -0.91304M -0.51093M
Net borrowings - -0.09039M -0.04446M -0.02092M -0.02092M
Total cash from financing activities -0.15035M -0.09039M 9.71M -0.02092M 0.01M
Change to operating activities - - - - -
Net income -2.24388M -2.77754M -2.26302M -1.13234M -0.33495M
Change in cash -1.83490M -3.45713M 6.78M -1.97676M -1.19964M
Begin period cash flow 3.83M 7.29M 0.50M 2.48M 3.68M
End period cash flow 1.99M 3.83M 7.29M 0.50M 2.48M
Total cash from operating activities -0.68329M -1.61866M -1.02103M -1.01411M -0.70168M
Issuance of capital stock - 0.00000M 10.39M 0.00000M 0.01M
Depreciation 0.69M 0.59M 0.62M 0.52M 0.43M
Other cashflows from investing activities - 0.00010M 0.00573M 0.00081M 0.00168M
Dividends paid - - - - -
Change to inventory -0.18036M -0.29693M -0.15600M -0.05377M 0.19M
Change to account receivables - 0.51M 0.24M -0.90803M 0.15M
Sale purchase of stock - - - - -
Other cashflows from financing activities -1.05400M -1.72610M -0.68339M -0.91304M -0.51093M
Change to netincome - 0.20M 0.44M 0.22M 0.02M
Capital expenditures 1.05M 1.73M 1.90M 0.91M 0.51M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.06432M 0.38M 0.19M -0.60444M -0.81581M
Stock based compensation 0.15M 0.64M 0.12M 0.21M 0.09M
Other non cash items 0.79M 0.12M 0.02M 0.08M -0.06616M
Free cash flow -1.73748M -3.34485M -2.92308M -1.92796M -1.21430M

Fundamentals

  • Previous Close 4.15
  • Market Cap31.20M
  • Volume1526850
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.18290M
  • Revenue TTM1.93M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM 0.56M
  • Diluted EPS TTM-0.02

Peer Comparison

Sector: Basic Materials Industry: Agricultural Inputs

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EDEN
Eden Research plc		 0.05 1.20% 4.20 - - 17.28 6.73 17.17 -4.9542
WYN
Wynnstay Group Plc		 - -% 390.00 5.78 11.09 0.11 0.63 0.13 4.08
EML
Emmerson PLC		 -0.1 5.26% 1.80 - - - 0.63 -2.5513
KRPZ
Kropz Plc		 -0.21 9.55% 1.99 - - 0.99 0.38 4.57 1.03
PHC
Plant Health Care		 -0.175 2.95% 5.75 - 21.46 1.06 1.33 0.65 -1.5855

Reports Covered

Stock Research & News

View All

Profile

Eden Research plc, together with its subsidiaries, offers sustainable solutions for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, deodorants, odor neutralizers, fragrances, wound care products, food flavorings, and active ingredient supply/delivery products. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Eden Research plc

67C Innovation Drive, Abingdon, United Kingdom, OX14 4RQ

Key Executives

Name Title Year Born
Mr. Sean M. Smith CEO & Exec. Director NA
Mr. Alexander John Abrey CFO, Sec. & Exec. Director NA
Dr. Aoife Dillon Global Head of Biology & Devel. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions